Shortage Avoided

DEFEROXAMINE MESYLATE FOR INJECTION

PFIZER CANADA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of DEFEROXAMINE MESYLATE FOR INJECTION in Canada?

Not currently. The most recent shortage report for DEFEROXAMINE MESYLATE FOR INJECTION 2G is marked resolved (last updated December 5, 2022).

Can I still get this?Check with your pharmacist

StatusShortage Avoided

Same-ingredient products on fileNone found

Affected strength2G

Last updated2022-12-05

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02247022

Strength

Dosage Form

POWDER FOR SOLUTION

Route

SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR

Active Ingredient

DEFEROXAMINE MESYLATE

Tier

Unrated

Last Updated

2022-12-05

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from PFIZER CANADA ULC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

40MG · DIN 02511053

20MG · DIN 02511061

40MG · DIN 02511045

DIN 02544040

5MG · DIN 01947664

10MG · DIN 01947672